# Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

> **NCT00077012** · PHASE1,PHASE2 · COMPLETED · sponsor: **QLT Inc.**

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** QLT0074
- **DRUG:** Photodynamic therapy

## Key facts

- **NCT ID:** NCT00077012
- **Lead sponsor:** QLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077012, "Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00077012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*